The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for T Yoshida


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.EBI
Ajinomoto
Correlation analyses on binding affinity of substituted benzenesulfonamides with carbonic anhydrase using ab initio MO calculations on their complex structures (II).EBI
The University of Tokushima Graduate School
Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.EBI
Mitsubishi Tanabe Pharma
Synthesis of phenserine analogues and evaluation of their cholinesterase inhibitory activities.EBI
Meiji Pharmaceutical University
Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.EBI
Mitsubishi Tanabe Pharma
Discovery of potent and orally active tricyclic-based FBPase inhibitors.EBI
Daiichi Sankyo
Lead optimization of [(S)-gamma-(arylamino)prolyl]thiazolidine focused on gamma-substituent: Indoline compounds as potent DPP-IV inhibitors.EBI
Mitsubishi Pharma
Synthesis and phospholipase A2 inhibitory activity of thielocin B3 derivatives.EBI
Shionogi
Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.EBI
Minase Research Institute
3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.EBI
Minase Research Institute
A prodrug approach towards the development of tricyclic-based FBPase inhibitors.EBI
Daiichi Sankyo
[(S)-gamma-(4-Aryl-1-piperazinyl)-l-prolyl]thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors.EBI
Mitsubishi Pharma
5-EBI
University of Toyama
Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure.EBI
Tokyo University of Pharmacy and Life Sciences
Hexylitaconic acid: a new inhibitor of p53-HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.EBI
Kanazawa University
2-pyridyloxy-4-nitrile orexin receptor antagonistsBDB
TBA